company background image
CELL logo

PhenomeX NasdaqGS:CELL Stock Report

Last Price

US$1.00

Market Cap

US$99.6m

7D

0.5%

1Y

-68.2%

Updated

04 Oct, 2023

Data

Company Financials +

PhenomeX Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PhenomeX
Historical stock prices
Current Share PriceUS$1.00
52 Week HighUS$3.65
52 Week LowUS$0.38
Beta0.94
1 Month Change2.90%
3 Month Change116.98%
1 Year Change-68.21%
3 Year Change-98.85%
5 Year Changen/a
Change since IPO-98.48%

Recent News & Updates

Recent updates

Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

May 16
Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Apr 17
PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Aug 15
Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Mehul Joshi joins Berkeley Lights as CFO

Jul 25

Berkeley Lights Grows Revenue But Operating Losses Mount

Dec 09

Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?

Nov 07
Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?

Berkeley Lights: Short Seller Report Raises A Few Legitimate Questions

Sep 23

Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development

Jun 09

Berkeley Lights Q1 2021 Earnings Preview

May 10

Shareholder Returns

CELLUS Life SciencesUS Market
7D0.5%-0.2%0.4%
1Y-68.2%4.5%28.8%

Return vs Industry: CELL underperformed the US Life Sciences industry which returned -13.4% over the past year.

Return vs Market: CELL underperformed the US Market which returned 14.1% over the past year.

Price Volatility

Is CELL's price volatile compared to industry and market?
CELL volatility
CELL Average Weekly Movement40.4%
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: CELL's share price has been volatile over the past 3 months.

Volatility Over Time: CELL's weekly volatility has increased from 23% to 40% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a285Siddhartha Kadiahttps://phenomex.com

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease.

PhenomeX Inc. Fundamentals Summary

How do PhenomeX's earnings and revenue compare to its market cap?
CELL fundamental statistics
Market capUS$99.63m
Earnings (TTM)-US$124.53m
Revenue (TTM)US$71.82m

1.4x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CELL income statement (TTM)
RevenueUS$71.82m
Cost of RevenueUS$25.32m
Gross ProfitUS$46.50m
Other ExpensesUS$171.03m
Earnings-US$124.53m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.25
Gross Margin64.75%
Net Profit Margin-173.40%
Debt/Equity Ratio0%

How did CELL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.